Cargando…

Post-Vaccination Coronavirus Disease 2019: A Case-Control Study and Genomic Analysis of 119 Breakthrough Infections in Partially Vaccinated Individuals( )

BACKGROUND: Post-vaccination infections challenge the control of the coronavirus disease 2019 (COVID-19) pandemic. METHODS: We matched 119 cases of post-vaccination severe acute respiratory syndrome coronavirus 2 infection with BNT162b2 mRNA or ChAdOx1 nCOV-19 to 476 unvaccinated patients with COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baltas, Ioannis, Boshier, Florencia A T, Williams, Charlotte A, Bayzid, Nadua, Cotic, Marius, Afonso Guerra-Assunção, José, Irish-Tavares, Dianne, Haque, Tanzina, Hart, Jennifer, Roy, Sunando, Williams, Rachel, Breuer, Judith, Mahungu, Tabitha W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513403/ https://www.ncbi.nlm.nih.gov/pubmed/34410361 http://dx.doi.org/10.1093/cid/ciab714

Ejemplares similares

2299. A London Hospital’s Experience of Confirmed Measles Infections and Re-Infections Between 2009 and 2019
por: Sturdy, Ann, et al.
Publicado: (2019)

Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre
por: Lee, Nathaniel, et al.
Publicado: (2022)

Whole-genome Sequencing Provides Data for Stratifying Infection Prevention and Control Management of Nosocomial Influenza A
por: Roy, Sunando, et al.
Publicado: (2019)

Vaccine breakthrough infections in veterans hospitalized with coronavirus infectious disease-2019: A case series
por: Kim, Paul S., et al.
Publicado: (2022)

A SARS-CoV-2 outbreak associated with vaccine breakthrough in an acute care hospital
por: Park, Se Yoon, et al.
Publicado: (2022)

High-Dose Influenza Vaccine Is Associated With Reduced Mortality Among Older Adults With Breakthrough Influenza Even When There Is Poor Vaccine-Strain Match
por: Chaves, Sandra S, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2 Delta Vaccine Breakthrough Transmissibility in Alachua County, Florida
por: Rife Magalis, Brittany, et al.
Publicado: (2022)

Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab
por: Hall, Victoria G, et al.
Publicado: (2023)

Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue Distribution
por: Ke, Ruian, et al.
Publicado: (2022)

Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects
por: Duarte, Luisa F, et al.
Publicado: (2023)

Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort
por: Bonazzetti, Cecilia, et al.
Publicado: (2023)

Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections
por: Singh, Gagandeep, et al.
Publicado: (2023)

Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine
por: Mwimanzi, Francis, et al.
Publicado: (2023)

Progression to Critical Illness and Death in Patients With Breakthrough Hospitalizations
por: Suleyman, Geehan, et al.
Publicado: (2022)

Measuring Vaccine Efficacy Against Infection and Disease in Clinical Trials: Sources and Magnitude of Bias in Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy Estimates
por: Williams, Lucy R, et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study
por: Yamamoto, Shohei, et al.
Publicado: (2021)

Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study
por: Kabbani, Dima, et al.
Publicado: (2023)

No Immunological Interference or Safety Concerns When Adjuvanted Recombinant Zoster Vaccine Is Coadministered With a Coronavirus Disease 2019 mRNA-1273 Booster Vaccine in Adults Aged 50 Years and Older: A Randomized Trial
por: Naficy, Abdi, et al.
Publicado: (2023)

Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections
por: Suleyman, Geehan, et al.
Publicado: (2022)

A National Implementation Project to Prevent Healthcare-Associated Infections in Intensive Care Units: A Collaborative Initiative Using the Breakthrough Series Model
por: Tuma, Paula, et al.
Publicado: (2023)

Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study
por: Isfordink, Cas, et al.
Publicado: (2022)

Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London
por: Bramley, Alexandra, et al.
Publicado: (2021)

Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
por: Bruxvoort, Katia J, et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Nonspecific Effects of Oral Polio Vaccine on Diarrheal Burden and Etiology Among Bangladeshi Infants
por: Upfill-Brown, Alexander, et al.
Publicado: (2017)

Getting Personal: How Childhood Vaccination Policies Shape the Landscape of Vaccine Exemptions
por: Garnier, Romain, et al.
Publicado: (2020)

Immune Response Kinetics Following a Third Heterologous BNT162b2 Booster Dose After Primary 2-Dose ChAdOx1 Vaccination in Relation to Omicron Breakthrough Infection: A Prospective Nationwide Cohort Study in South Korea
por: Ahn, Jin Young, et al.
Publicado: (2023)

Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy
por: Haque, Azizul, et al.
Publicado: (2022)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

$^{119}$Sn Mössbauer study of the implantation behaviour of $^{119}$In, $^{119}$Sn, $^{119m}$Sn, $^{119}$Sb and $^{119m}$Te ions in SiC
por: Petersen, J W, et al.
Publicado: (1985)

Vaccines in Breast Cancer: Challenges and Breakthroughs
por: Fatima, Gul Naz, et al.
Publicado: (2023)

The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01(E) Malaria Vaccine( )
por: Sagara, Issaka, et al.
Publicado: (2021)

Vaccination Coverage and Risk Factors Associated With Incomplete Vaccination Among Children in Cambodia, Madagascar, and Senegal
por: Verrier, Florian, et al.
Publicado: (2023)

Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis
por: Okoli, George N, et al.
Publicado: (2021)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

The decay of $]^{119}$Cd and $\^{119}$In isomers
por: Scheidemann, O, et al.
Publicado: (1976)

Observational Study Evaluating the Seroprotection of HepB-alum Vaccine and HepB-CpG Vaccine in People With HIV
por: Reilly-Evans, Brenna, et al.
Publicado: (2023)

SARS-CoV-2 antigen rapid tests and universal screening for COVID-19 Omicron variant among hospitalized children
por: Kam, Kai-Qian, et al.
Publicado: (2023)

Pneumococcal Conjugate Vaccine Safety in Elderly Adults
por: Tseng, Hung Fu, et al.
Publicado: (2018)

Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019–2020 Influenza Season
por: Imran, Mahrukh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_34amr772vg6gg48eqdbdfbimgt